Comment
doi: 10.1007/s11883-007-0021-8.
SPARCL: statin therapy for stroke patients is not crystal clear
- PMID: 18241615
- DOI: 10.1007/s11883-007-0021-8
Item in Clipboard
Comment
SPARCL: statin therapy for stroke patients is not crystal clear
Curr Atheroscler Rep.
2007 Sep.
No abstract available
Comment on
-
High-dose atorvastatin after stroke or transient ischemic attack.N Engl J Med. 2006 Aug 10;355(6):549-59. doi: 10.1056/NEJMoa061894. N Engl J Med. 2006. PMID: 16899775 Clinical Trial.
Similar articles
-
[Statins in the secondary prevention of stroke: New evidence from the SPARCL Study].Clin Investig Arterioscler. 2016 Jul-Aug;28(4):202-8. doi: 10.1016/j.arteri.2015.05.002. Epub 2015 Jul 3. Clin Investig Arterioscler. 2016. PMID: 26150172 Spanish.
-
SPARCL: the glimmer of statins for stroke risk reduction.Curr Atheroscler Rep. 2007 Nov;9(5):347-51. doi: 10.1007/s11883-007-0044-1. Curr Atheroscler Rep. 2007. PMID: 18001616 Clinical Trial.
-
Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke.Stroke. 2010 Jul;41(7):1508-13. doi: 10.1161/STROKEAHA.109.573618. Epub 2010 May 27. Stroke. 2010. PMID: 20508182
-
Statins in Ischemic Stroke Prevention: What Have We Learned in the Post-SPARCL (The Stroke Prevention by Aggressive Reduction in Cholesterol Levels) Decade?Curr Treat Options Neurol. 2019 Apr 8;21(5):22. doi: 10.1007/s11940-019-0563-4. Curr Treat Options Neurol. 2019. PMID: 30957208 Review.
-
Drug insight: translating evidence on statin therapy into clinical benefits.Nat Clin Pract Neurol. 2008 Jan;4(1):43-9. doi: 10.1038/ncpneuro0705. Nat Clin Pract Neurol. 2008. PMID: 18199996 Review.